Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

United States Cervical Cancer Diagnostic Market Report 2017

  • QYR1003861
  • 108 Pages
  • February 2017
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Cervical Cancer Diagnostic

Revenue, means the sales value of Cervical Cancer Diagnostic

This report studies sales (consumption) of Cervical Cancer Diagnostic in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Laboratories

F. Hoffmann-La Roche Ltd

QIAGEN

Quest Diagnostics, Inc

Hologic, Inc.

Arbor Vita Corporation

OncoHealth Corporation

Dell Guided Therapeutics, Inc.

Cooper Surgical, Inc.

Becton, Dickinson and Company

Guided Therapeutics

Siemens

Zilico Ltd

Beckman Coulter, Inc.

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pap Testing

HPV Testing

Colposcopy

Cervical Biopsies

Cystoscopy

Split by applications, this report focuses on sales, market share and growth rate of Cervical Cancer Diagnostic in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Cervical Cancer Diagnostic Market Report 2017

1 Cervical Cancer Diagnostic Overview

1.1 Product Overview and Scope of Cervical Cancer Diagnostic

1.2 Classification of Cervical Cancer Diagnostic

1.2.1 Pap Testing

1.2.2 HPV Testing

1.2.3 Colposcopy

1.2.4 Cervical Biopsies

1.2.5 Cystoscopy

1.3 Application of Cervical Cancer Diagnostic

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cervical Cancer Diagnostic (2012-2022)

1.4.1 United States Cervical Cancer Diagnostic Sales and Growth Rate (2012-2022)

1.4.2 United States Cervical Cancer Diagnostic Revenue and Growth Rate (2012-2022)

2 United States Cervical Cancer Diagnostic Competition by Manufacturers

2.1 United States Cervical Cancer Diagnostic Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Cervical Cancer Diagnostic Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Cervical Cancer Diagnostic Average Price by Manufactures (2015 and 2016)

2.4 Cervical Cancer Diagnostic Market Competitive Situation and Trends

2.4.1 Cervical Cancer Diagnostic Market Concentration Rate

2.4.2 Cervical Cancer Diagnostic Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Cervical Cancer Diagnostic Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Cervical Cancer Diagnostic Sales and Market Share by States (2012-2017)

3.2 United States Cervical Cancer Diagnostic Revenue and Market Share by States (2012-2017)

3.3 United States Cervical Cancer Diagnostic Price by States (2012-2017)

4 United States Cervical Cancer Diagnostic Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Cervical Cancer Diagnostic Sales and Market Share by Type (2012-2017)

4.2 United States Cervical Cancer Diagnostic Revenue and Market Share by Type (2012-2017)

4.3 United States Cervical Cancer Diagnostic Price by Type (2012-2017)

4.4 United States Cervical Cancer Diagnostic Sales Growth Rate by Type (2012-2017)

5 United States Cervical Cancer Diagnostic Sales (Volume) by Application (2012-2017)

5.1 United States Cervical Cancer Diagnostic Sales and Market Share by Application (2012-2017)

5.2 United States Cervical Cancer Diagnostic Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Cervical Cancer Diagnostic Manufacturers Profiles/Analysis

6.1 Abbott Laboratories

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abbott Laboratories Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 F. Hoffmann-La Roche Ltd

6.2.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 F. Hoffmann-La Roche Ltd Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 QIAGEN

6.3.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 QIAGEN Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Quest Diagnostics, Inc

6.4.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Quest Diagnostics, Inc Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Hologic, Inc.

6.5.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Hologic, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Arbor Vita Corporation

6.6.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Arbor Vita Corporation Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 OncoHealth Corporation

6.7.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 OncoHealth Corporation Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Dell Guided Therapeutics, Inc.

6.8.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Cooper Surgical, Inc.

6.9.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Cooper Surgical, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Becton, Dickinson and Company

6.10.2 Cervical Cancer Diagnostic Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Becton, Dickinson and Company Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Guided Therapeutics

6.12 Siemens

6.13 Zilico Ltd

6.14 Beckman Coulter, Inc.

7 Cervical Cancer Diagnostic Manufacturing Cost Analysis

7.1 Cervical Cancer Diagnostic Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Cervical Cancer Diagnostic

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Cervical Cancer Diagnostic Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Cervical Cancer Diagnostic Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Cervical Cancer Diagnostic Market Forecast (2017-2022)

11.1 United States Cervical Cancer Diagnostic Sales, Revenue Forecast (2017-2022)

11.2 United States Cervical Cancer Diagnostic Sales Forecast by Type (2017-2022)

11.3 United States Cervical Cancer Diagnostic Sales Forecast by Application (2017-2022)

11.4 Cervical Cancer Diagnostic Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Cervical Cancer Diagnostic

Table Classification of Cervical Cancer Diagnostic

Figure United States Sales Market Share of Cervical Cancer Diagnostic by Type in 2015

Figure Pap Testing Picture

Figure HPV Testing Picture

Figure Colposcopy Picture

Figure Cervical Biopsies Picture

Figure Cystoscopy Picture

Table Application of Cervical Cancer Diagnostic

Figure United States Sales Market Share of Cervical Cancer Diagnostic by Application in 2015

Figure United States Cervical Cancer Diagnostic Sales and Growth Rate (2012-2022)

Figure United States Cervical Cancer Diagnostic Revenue and Growth Rate (2012-2022)

Table United States Cervical Cancer Diagnostic Sales of Key Manufacturers (2015 and 2016)

Table United States Cervical Cancer Diagnostic Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Cervical Cancer Diagnostic Sales Share by Manufacturers

Figure 2016 Cervical Cancer Diagnostic Sales Share by Manufacturers

Table United States Cervical Cancer Diagnostic Revenue by Manufacturers (2015 and 2016)

Table United States Cervical Cancer Diagnostic Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Cervical Cancer Diagnostic Revenue Share by Manufacturers

Table 2016 United States Cervical Cancer Diagnostic Revenue Share by Manufacturers

Table United States Market Cervical Cancer Diagnostic Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Cervical Cancer Diagnostic Average Price of Key Manufacturers in 2015

Figure Cervical Cancer Diagnostic Market Share of Top 3 Manufacturers

Figure Cervical Cancer Diagnostic Market Share of Top 5 Manufacturers

Table United States Cervical Cancer Diagnostic Sales by States (2012-2017)

Table United States Cervical Cancer Diagnostic Sales Share by States (2012-2017)

Figure United States Cervical Cancer Diagnostic Sales Market Share by States in 2015

Table United States Cervical Cancer Diagnostic Revenue and Market Share by States (2012-2017)

Table United States Cervical Cancer Diagnostic Revenue Share by States (2012-2017)

Figure Revenue Market Share of Cervical Cancer Diagnostic by States (2012-2017)

Table United States Cervical Cancer Diagnostic Price by States (2012-2017)

Table United States Cervical Cancer Diagnostic Sales by Type (2012-2017)

Table United States Cervical Cancer Diagnostic Sales Share by Type (2012-2017)

Figure United States Cervical Cancer Diagnostic Sales Market Share by Type in 2015

Table United States Cervical Cancer Diagnostic Revenue and Market Share by Type (2012-2017)

Table United States Cervical Cancer Diagnostic Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cervical Cancer Diagnostic by Type (2012-2017)

Table United States Cervical Cancer Diagnostic Price by Type (2012-2017)

Figure United States Cervical Cancer Diagnostic Sales Growth Rate by Type (2012-2017)

Table United States Cervical Cancer Diagnostic Sales by Application (2012-2017)

Table United States Cervical Cancer Diagnostic Sales Market Share by Application (2012-2017)

Figure United States Cervical Cancer Diagnostic Sales Market Share by Application in 2015

Table United States Cervical Cancer Diagnostic Sales Growth Rate by Application (2012-2017)

Figure United States Cervical Cancer Diagnostic Sales Growth Rate by Application (2012-2017)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Abbott Laboratories Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table F. Hoffmann-La Roche Ltd Basic Information List

Table F. Hoffmann-La Roche Ltd Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table F. Hoffmann-La Roche Ltd Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table QIAGEN Basic Information List

Table QIAGEN Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table QIAGEN Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Quest Diagnostics, Inc Basic Information List

Table Quest Diagnostics, Inc Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Quest Diagnostics, Inc Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Hologic, Inc. Basic Information List

Table Hologic, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Hologic, Inc. Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Arbor Vita Corporation Basic Information List

Table Arbor Vita Corporation Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Arbor Vita Corporation Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table OncoHealth Corporation Basic Information List

Table OncoHealth Corporation Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table OncoHealth Corporation Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Dell Guided Therapeutics, Inc. Basic Information List

Table Dell Guided Therapeutics, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Dell Guided Therapeutics, Inc. Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Cooper Surgical, Inc. Basic Information List

Table Cooper Surgical, Inc. Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Cooper Surgical, Inc. Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Becton, Dickinson and Company Basic Information List

Table Becton, Dickinson and Company Cervical Cancer Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)

Table Becton, Dickinson and Company Cervical Cancer Diagnostic Sales Market Share (2012-2017)

Table Guided Therapeutics Basic Information List

Table Siemens Basic Information List

Table Zilico Ltd Basic Information List

Table Beckman Coulter, Inc. Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cervical Cancer Diagnostic

Figure Manufacturing Process Analysis of Cervical Cancer Diagnostic

Figure Cervical Cancer Diagnostic Industrial Chain Analysis

Table Raw Materials Sources of Cervical Cancer Diagnostic Major Manufacturers in 2015

Table Major Buyers of Cervical Cancer Diagnostic

Table Distributors/Traders List

Figure United States Cervical Cancer Diagnostic Production and Growth Rate Forecast (2017-2022)

Figure United States Cervical Cancer Diagnostic Revenue and Growth Rate Forecast (2017-2022)

Table United States Cervical Cancer Diagnostic Production Forecast by Type (2017-2022)

Table United States Cervical Cancer Diagnostic Consumption Forecast by Application (2017-2022)

Table United States Cervical Cancer Diagnostic Sales Forecast by States (2017-2022)

Table United States Cervical Cancer Diagnostic Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370